WO1997018323A3 - Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity - Google Patents
Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity Download PDFInfo
- Publication number
- WO1997018323A3 WO1997018323A3 PCT/US1996/019337 US9619337W WO9718323A3 WO 1997018323 A3 WO1997018323 A3 WO 1997018323A3 US 9619337 W US9619337 W US 9619337W WO 9718323 A3 WO9718323 A3 WO 9718323A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pik
- cycle checkpoint
- cell cycle
- phosphatidylinositol
- assaying
- Prior art date
Links
- 230000012820 cell cycle checkpoint Effects 0.000 title abstract 4
- 230000002255 enzymatic effect Effects 0.000 title 1
- 108060006633 protein kinase Proteins 0.000 title 1
- 102000017343 Phosphatidylinositol kinases Human genes 0.000 abstract 4
- 108050005377 Phosphatidylinositol kinases Proteins 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000016563 PIK-related kinases Human genes 0.000 abstract 2
- 108050006107 PIK-related kinases Proteins 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 230000005778 DNA damage Effects 0.000 abstract 1
- 231100000277 DNA damage Toxicity 0.000 abstract 1
- 230000033616 DNA repair Effects 0.000 abstract 1
- 230000004543 DNA replication Effects 0.000 abstract 1
- -1 MCCS1 Proteins 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000022131 cell cycle Effects 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 230000011278 mitosis Effects 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000028617 response to DNA damage stimulus Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI973005A FI973005L (en) | 1995-11-16 | 1996-11-18 | Cell cycle checkpoint PIK-related kinase materials and methods |
| MX9705466A MX9705466A (en) | 1995-11-16 | 1996-11-18 | Cell cycle checkpoint pik-related kinase materials and methods. |
| HU0002207A HUP0002207A2 (en) | 1996-10-21 | 1996-11-18 | Cell cycle checkpoint pik-related kinase materials and methods |
| SK1115-97A SK111597A3 (en) | 1995-11-16 | 1996-11-18 | Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity |
| IL12130696A IL121306A0 (en) | 1995-11-16 | 1996-11-18 | Cell cycle checkpoint pik-related kinase materials and methods |
| EP96945181A EP0807169A3 (en) | 1995-11-16 | 1996-11-18 | Cell cycle checkpoint pik-related kinase materials and methods |
| AU14611/97A AU1461197A (en) | 1995-11-16 | 1996-11-18 | Cell cycle checkpoint pik-related kinase materials and methods |
| JP51918097A JP2002515732A (en) | 1995-11-16 | 1996-11-18 | Cell cycle checkpoint PIK-related kinase substances and methods |
| NO973279A NO973279L (en) | 1995-11-16 | 1997-07-15 | PIK-related kinase materials and cell cycle checkpoint methods |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55866695A | 1995-11-16 | 1995-11-16 | |
| US08/558,666 | 1995-11-16 | ||
| US73129696A | 1996-02-27 | 1996-02-27 | |
| US08/007,312 | 1996-02-27 | ||
| US72530496A | 1996-10-21 | 1996-10-21 | |
| US08/725,304 | 1996-10-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1997018323A2 WO1997018323A2 (en) | 1997-05-22 |
| WO1997018323A3 true WO1997018323A3 (en) | 1997-10-09 |
Family
ID=27415779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1996/019337 WO1997018323A2 (en) | 1995-11-16 | 1996-11-18 | Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN1199420A (en) |
| AU (1) | AU1461197A (en) |
| IL (1) | IL121306A0 (en) |
| NO (1) | NO973279L (en) |
| PL (1) | PL322876A1 (en) |
| WO (1) | WO1997018323A2 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858661A (en) * | 1995-05-16 | 1999-01-12 | Ramot-University Authority For Applied Research And Industrial Development | Ataxia-telangiectasia gene and its genomic organization |
| US5777093A (en) * | 1995-05-16 | 1998-07-07 | Ramot-University Authority For Applied Research & Industrial Development Ltd. | cDNAs associated with ataxia-telangiectasia |
| GB9518220D0 (en) * | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
| WO1999002653A1 (en) * | 1997-07-11 | 1999-01-21 | Trustees Of The University Of Pennsylvania | Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use |
| GB9714971D0 (en) | 1997-07-16 | 1997-09-24 | Cancer Res Campaign Tech | Assays,therapeutic methods and means |
| GB9718952D0 (en) * | 1997-09-05 | 1997-11-12 | Medical Res Council | Mammalian chk1 effector cell cycle checkpoint protein kinase materials and methods |
| CA2216559A1 (en) * | 1997-09-25 | 1999-03-25 | Michel Roberge | G2 checkpoint inhibitors and assay |
| GB9722320D0 (en) * | 1997-10-22 | 1997-12-17 | Janssen Pharmaceutica Nv | Human cell cycle checkpoint proteins |
| US6071691A (en) * | 1998-04-27 | 2000-06-06 | Oregon Health Science University | Materials and methods for modulating differentiation |
| US6387640B1 (en) | 1999-02-10 | 2002-05-14 | St. Jude Children's Research Hospital | ATM kinase modulation for screening and therapies |
| US6348311B1 (en) | 1999-02-10 | 2002-02-19 | St. Jude Childre's Research Hospital | ATM kinase modulation for screening and therapies |
| US6670167B1 (en) | 1999-11-01 | 2003-12-30 | Agouron Pharmaceuticals, Inc. | Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof |
| GB0119865D0 (en) | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
| GB0119863D0 (en) | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
| US7049313B2 (en) | 2002-02-25 | 2006-05-23 | Kudos Pharmaceuticals Ltd. | ATM inhibitors |
| US20040142894A1 (en) * | 2002-10-25 | 2004-07-22 | Stein Gary S. | Modulation of cellular proliferation |
| GB2420781B (en) | 2003-08-13 | 2008-07-09 | Kudos Pharm Ltd | Aminopyrones and their use as ATM inhibitors |
| TW200616986A (en) | 2004-09-20 | 2006-06-01 | Kudos Pharm Ltd | DNA-pk inhibitors |
| EP1848712A1 (en) | 2005-02-09 | 2007-10-31 | Kudos Pharmaceuticals Ltd | Atm inhibitors |
| AR054438A1 (en) | 2005-04-15 | 2007-06-27 | Kudos Pharm Ltd | DNA INHIBITORS -PK |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997009433A1 (en) * | 1995-09-06 | 1997-03-13 | Icos Corporation | Cell-cycle checkpoint genes |
-
1996
- 1996-11-18 AU AU14611/97A patent/AU1461197A/en not_active Abandoned
- 1996-11-18 CN CN96192586.8A patent/CN1199420A/en active Pending
- 1996-11-18 PL PL96322876A patent/PL322876A1/en unknown
- 1996-11-18 IL IL12130696A patent/IL121306A0/en unknown
- 1996-11-18 WO PCT/US1996/019337 patent/WO1997018323A2/en not_active Application Discontinuation
-
1997
- 1997-07-15 NO NO973279A patent/NO973279L/en not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997009433A1 (en) * | 1995-09-06 | 1997-03-13 | Icos Corporation | Cell-cycle checkpoint genes |
Non-Patent Citations (5)
| Title |
|---|
| BENTLEY, N.J. ET AL.: "The Schizosaccharomyces pombe rad3 checkpoint gene", EMBO JOURNAL, vol. 15, no. 23, 1996, pages 6641 - 6651, XP002023634 * |
| CIMPRICH, K.A. ET AL.: "cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 93, April 1996 (1996-04-01), pages 2850 - 2855, XP002023632 * |
| HOEKSTRA, M.F.: "Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family", CURRENT OPINION GENET. DEV., vol. 7, no. 2, 1997, pages 170 - 175, XP002036687 * |
| SAVITSKY, K. ET AL.: "A single ataxia telangiectasia gene with a product similar to PI-3 kinase", SCIENCE, vol. 268, 23 June 1995 (1995-06-23), pages 1749 - 1753, XP002036686 * |
| SEATON, B.L. ET AL.: "Isolation and characterization of the Schizosaccharomyces pombe rad3 gene, involved in the DNA damage and DNA synthesis checkpoints", GENE, vol. 119, 1992, pages 83 - 89, XP002023633 * |
Also Published As
| Publication number | Publication date |
|---|---|
| NO973279D0 (en) | 1997-07-15 |
| WO1997018323A2 (en) | 1997-05-22 |
| PL322876A1 (en) | 1998-03-02 |
| AU1461197A (en) | 1997-06-05 |
| IL121306A0 (en) | 1998-01-04 |
| NO973279L (en) | 1997-09-16 |
| CN1199420A (en) | 1998-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1997018323A3 (en) | Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity | |
| US6114148C1 (en) | High level expression of proteins | |
| AU6414196A (en) | A modified enzyme with lipolytic activity | |
| EP1097994A3 (en) | Human bad polypeptides, encoding nucleic acids and methods of use | |
| AU8719291A (en) | Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases | |
| DE69841723D1 (en) | EXPRESSION OF ENDOGENIC GENES THROUGH HOMOLOGOUS RECOMBINATION OF A VECTOR CONSTRUCTURE WITH CELLULAR DNA | |
| NZ323795A (en) | Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides | |
| WO2003027634A3 (en) | Identification of modulatory molecules using inducible promoters | |
| DE69434614D1 (en) | CDN APOPTOSIS MODULATING PROTEINS, THE ENCODING DNA, AND METHOD FOR THEIR USE | |
| EP1102988B8 (en) | Method of determining the immune response activity of blood and test kit therefor | |
| MXPA98003564A (en) | Plant vde genes and methods related thereto. | |
| BR9912455A (en) | nucleic acids encoding proteins involved in sensory transduction | |
| DE69830066D1 (en) | Lunasin peptide | |
| CA2173102A1 (en) | Dna sequence coding for a bmp receptor | |
| EP1005539A4 (en) | IKK-$g(a) PROTEINS, NUCLEIC ACIDS AND METHODS | |
| NO972063L (en) | Isolated BMP receptor kinase protein, DNA sequence, recombinant expression vector and host cell | |
| ATE205600T1 (en) | LEUKOCYTE ADHESION TEST | |
| MX9705466A (en) | Cell cycle checkpoint pik-related kinase materials and methods. | |
| FI973005L (en) | Cell cycle checkpoint PIK-related kinase materials and methods | |
| WO1995000554A3 (en) | Totipotent hematopoietic stem cell receptors and their ligands | |
| AU4917300A (en) | Method for producing a recombinant protein | |
| WO1998024902A8 (en) | Adaptor protein frs2 and related products and methods | |
| MX9606257A (en) | Bts1 geranylgeranyl disphosphate synthase in saccharomyces cerevisiae. | |
| WO1999047709A3 (en) | Methods for identifying anti-cancer agents | |
| AU6667496A (en) | A method and kit for evaluating the metastatic tendency of tumors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 96192586.8 Country of ref document: CN |
|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 973005 Country of ref document: FI |
|
| ENP | Entry into the national phase |
Ref document number: 2210650 Country of ref document: CA Ref document number: 2210650 Country of ref document: CA Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1997/005466 Country of ref document: MX |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PV1997-2547 Country of ref document: CZ |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 111597 Country of ref document: SK |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1996945181 Country of ref document: EP |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA |
|
| WWP | Wipo information: published in national office |
Ref document number: 1996945181 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: PV1997-2547 Country of ref document: CZ |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1996945181 Country of ref document: EP |
|
| WWR | Wipo information: refused in national office |
Ref document number: PV1997-2547 Country of ref document: CZ |